"Traffic light" food labels, prominent positioning of healthy items produce lasting purchase choice changes
The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice of more healthful food items among customers in a large hospital cafeteria. Read more.
Photo Credit: MGH Nutrition and Food Services
Services for the Media
3/05/14: Novel cancer vaccine holds promise against ovarian cancer, mesothelioma A new approach to cancer immunotherapy may provide a cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.
2/27/14: High-calorie feeding may slow progression of ALS Increasing the number of calories consumed by patients with amyotrophic lateral sclerosis may be a relatively simple way of extending their survival.
2/24/14: Specialized cognitive behavioral therapy improves blood sugar control in depressed patients with type 2 diabetes A program of cognitive behavioral therapy that addresses both mood and diabetes self-care led to improved blood sugar control and produced faster relief of depression in patients with poorly-controlled type 2 diabetes.
2/20/14: Survey finds rural primary care physicians as committed to professionalism, quality improvement as their urban counterparts A new study finds few meaningful differences between rural and urban primary care physicians on key measures of professionalism, including their attitudes about participation in quality care improvement.
2/12/14: Pregabalin effectively treats restless leg syndrome, less likely than dopamine drugs to worsen symptoms A year-long study has found that pregabalin – FDA-approved to treat nerve pain and seizures – was effective in reducing symptoms of restless leg syndrome and, with long-term treatment, was less likely than pramipexole – which activates the dopamine neurotransmission system and is FDA approved for RLS treatment – to cause worsening of symptoms.
2/17/14: First Huntington disease prevention trial shows treatment safety, suggests slowing of presymptomatic progression The first clinical trial of a drug to delay the onset of symptoms of Huntington disease reveals that high-dose treatment with the nutritional supplement creatine was safe and well tolerated by most study participants and might slow the progression of presymptomatic disease.
Newsletters & Publications
Hotline Each week, MGH Hotline reports important news within the Massachusetts General Hospital community featuring employees and initiatives that focus on bettering the future of clinical care, research and training.
Proto Proto, a magazine that reaches 75,000 thought leaders nationwide, stakes its ground on medicine's leading edge, reporting back from the frontiers of research and practice—exploring breakthroughs, dissecting controversies and opening a forum for informed debate.
Mass General Magazine Mass General Magazine takes you into the heart of the institution, describing ways in which Mass General is leading the way in educating physicians, nurses and other healthcare professionals; in improving the health of local and distant communities; and in establishing best practices and health policy.
03/07/2014: From Hallway Talk At Harvard Med School To New Student Review
mentions that MGH president Peter Slavin is on advisory board of new HMS student journal
03/06/2014: Boston researcher receives $8 million to expand Alzheimer’s study
White Coat Notes/Boston.com
coverage of study led by BWH/MGH investigator Reisa Sperling
03/06/2014: No Benefit to Earlier Use of Bone Drug in Prostate Cancer
coverage of study led by MGH investigator Matthew Smith
03/06/2014: Drug Shortage Woes
mentions measures taken at MGH to deal with shortage of blood pressure drug
03/05/2014: Deaf Toddler Hears For First Time With Device Implanted in Brainstem
mentions participation of MGH physicians in experimental procedure
03/05/2014: First Step to Creating HIV-Resistant T Cells in Patients
coverage quoting journal editorial co-authored by MGH investigator Bruce Walker